Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma

被引：0
|
作者：
Meiling Sun
Huaijun Ji
Ning Xu
Peng Jiang
Tao Qu
Yu Li
机构：
[1] Shandong University,Department of Pulmonary and Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine
[2] Weihai Municipal Hospital,Department of Respiratory Medicine
[3] Weihai Municipal Hospital,Department of Thoracic Surgery
来源：
BMC Cancer | / 22卷
关键词：
Immune checkpoint inhibitors (ICIs); PD-L1 inhibitor; NSCLC; Objective response rate; Disease control rate; Median progression-free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma
    Ichimiya, Yukako
    Alluri, Krishna
    Marcus, Charles
    Best, Simon
    Chung, Christine H.
    Subramaniam, Rathan M.
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 5 (02): : 154 - 161
  • [22] Induction immune checkpoint inhibitors and chemotherapy for patients with stage III non-small cell lung cancer: A real-world experience
    Zheng, Shuohan
    Sun, Ciming
    Zhang, Hao
    Xu, Huimin
    Dong, Baiqiang
    Hou, Zan
    Chen, Ming
    Li, Qiwen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Squamous cell carcinoma of the gingivobuccal complex: Predictors of locoregional failure in stage III-IV cancers
    Walvekar, Rohan R.
    Chaukar, Devendra A.
    Deshpande, Mandar S.
    Pai, Prathamesh S.
    Chaturvedi, Pankaj
    Kakade, Anagha
    D'Cruz, Anil K.
    ORAL ONCOLOGY, 2009, 45 (02) : 135 - 140
  • [24] PRIMARY SURGERY VERSUS CHEMORADIOTHERAPY IN PATIENTS WITH STAGE III-IV ORAL SQUAMOUS CELL CARCINOMA
    Kravets, O. V.
    Protsyk, V. S.
    Burtyn, O. V.
    Khlynin, O. V.
    Huryanov, V. H.
    WORLD OF MEDICINE AND BIOLOGY, 2019, 69 (03): : 77 - +
  • [25] Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data
    Toribio-Garcia, Irene
    Olivares-Hernandez, Alejandro
    Miramontes-Gonzalez, Jose Pablo
    Dominguez, Luis Posado
    Garcia, Ana Martin
    Bachiller, Rocio Eiros
    Figuero-Perez, Luis
    Martinez, Maria Garijo
    Ruiz, Jonnathan Roldan
    Hernandez, Lorena Bellido
    Fonseca-Sanchez, Emilio
    Sanchez, Pedro Luis
    del Barco-Morillo, Edel
    CANCERS, 2023, 15 (17)
  • [26] A real-world data of Immune checkpoint inhibitors in solid tumors from India
    Noronha, Vanita
    Abraham, George
    Patil, Vijay
    Joshi, Amit
    Menon, Nandini
    Mahajan, Abhishek
    Janu, Amit
    Jain, Srushti
    Talreja, Vikas T.
    Kapoor, Akhil
    Singh, Gunjesh Kumar
    Khaddar, Satvik
    Gupta, Kushal
    Rathinasamy, Narmadha
    Srinivas, Sujay
    Agrawal, Amit
    Ventrapati, Pradeep
    Prabhash, Kumar
    CANCER MEDICINE, 2021, 10 (05): : 1525 - 1534
  • [27] Real-world treatment pattern and prognostic factors of stage IV lung squamous cell carcinoma patients
    Hsu, En-Chi
    Wu, Kuan-Li
    Tsai, Ying-Ming
    Lee, Mei-Hsuan
    Tsai, Ming-Ju
    Kuo, Chia-Yu
    Liu, Yu-Chuan
    Liang, Fu-Wen
    Yang, Chih-Jen
    Hung, Jen-Yu
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2022, 38 (10): : 1001 - 1011
  • [28] Real-world treatment patterns and outcomes of patients with stage IV squamous cell carcinoma of the head and neck
    Byrne, Katherine
    Zanotti, Giovanni
    Hallworth, Pamela
    Roughley, Adam
    Martini, Jean-Francois
    Uehara, Roberto
    Iyer, Shrividya
    FUTURE ONCOLOGY, 2019, 15 (06) : 611 - 623
  • [29] Immune checkpoint inhibitors in sinonasal squamous cell carcinoma
    Park, Jong Chul
    Faquin, William C.
    Durbeck, Julia
    Faden, Daniel L.
    ORAL ONCOLOGY, 2020, 109
  • [30] Real-world treatment patterns in patients with advanced (stage III-IV) ovarian cancer in the USA and Europe
    Hall, Jennifer P.
    Chang, Jane
    Moon, Rebecca
    Higson, Olivia
    Byrne, Katherine
    Doherty, Jim P.
    Cappelleri, Joseph C.
    FUTURE ONCOLOGY, 2020, 16 (15) : 1013 - 1030
12345